CanSino Biologics, Inc. Class H (6185) Income Statement

5 Followers

CanSino Biologics, Inc. Class H Income Statement

Last quarter (Q4 2025), CanSino Biologics, Inc. Class H's total revenue was ¥369.80M, an increase of 32.42% from the same quarter last year. In Q4, CanSino Biologics, Inc. Class H's net income was ¥13.23M. See CanSino Biologics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	¥ 1.03B	¥ 846.34M	¥ 345.18M	¥ 1.03B	¥ 4.30B
Gross Profit	¥ 681.82M	¥ 601.91M	¥ -876.02M	¥ -186.61M	¥ 3.00B
Operating Expenses	¥ 794.94M	¥ 958.80M	¥ 1.16B	¥ 1.18B	¥ 1.20B
Depreciation and Amortization	¥ 174.10M	¥ 240.39M	¥ 269.05M	¥ 180.13M	¥ 65.11M
EBITDA	¥ 60.98M	¥ -134.84M	¥ -1.65B	¥ -1.32B	¥ 1.85B
Operating Income	¥ -113.12M	¥ -375.22M	¥ -2.04B	¥ -1.37B	¥ 1.94B
Other Income/Expenses	¥ 134.30M	¥ -5.98M	¥ 56.30M	¥ 184.74M	¥ -4.01M
Pretax Income	¥ 21.18M	¥ -381.20M	¥ -1.98B	¥ -1.18B	¥ 1.94B
Net Income	¥ 27.15M	¥ -378.88M	¥ -1.48B	¥ -909.43M	¥ 1.91B
Per Share Metrics
Basic EPS	¥ 0.11	¥ -1.53	¥ -6.01	¥ -3.68	¥ 7.74
Diluted EPS	¥ 0.11	¥ -1.53	¥ -6.01	¥ -3.68	¥ 7.74
Weighted Average Shares Outstanding	253.38M	247.64M	246.77M	247.02M	247.45M
Weighted Average Shares Outstanding (Diluted)	253.38M	247.64M	246.77M	247.02M	247.45M

Currency in CNY

CanSino Biologics, Inc. Class H (6185) Income Statement

CanSino Biologics, Inc. Class H Income Statement

CanSino Biologics, Inc. Class H Earnings and Revenue History